Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma

NCT00003821 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.

NCT NCT00003821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Lead sponsor
Genzyme, a Sanofi Company
Phase
Phase 2
Overall status
Withdrawn
Start date
January 31, 1998
Completion date
Not reported
Enrollment
0 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer